A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of treatment with carboplatin and
Abraxane in this patient population and determine the nature and degree of toxicities
following treatment. The single stage open label Phase II feasibility study is designed to
estimate the proportion of patients who can tolerate the proposed regimen for 6 cycles with
no more than two dose level reductions.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health